| [1] |
VOGELMEIER C F, ROMÁN-RODRÍGUEZ M, SINGH D, et al. Goals of COPD treatment: Focus on symptoms and exacerbations[J]. Respir Med, 2020, 166:105938. DOI:10.1016/j.rmed.2020.105938 .
|
| [2] |
PATEL N. An update on COPD prevention, diagnosis, and management: The 2024 GOLD Report[J]. Nurse Pract, 2024, 49(6):29-36. DOI:10.1097/01.NPR.0000000000000180 .
|
| [3] |
CHRISTENSON S A, SMITH B M, BAFADHEL M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342):2227-2242. DOI:10.1016/S0140-6736(22)00470-6 .
|
| [4] |
李丽球, 谢丽华, 孙圣华. 慢性阻塞性肺疾病动物模型的研究进展[J]. 中南大学学报(医学版), 2017, 42(9):1105-1110. DOI: 10.11817/j.issn.1672-7347.2017.09.018 .
|
|
LI L Q, XIE L H, SUN S H. Progress in study on animal models of chronic obstructive pulmonary disease[J]. J Cent South Univ Med Sci, 2017, 42(9):1105-1110. DOI: 10.11817/j.issn.1672-7347.2017.09.018 .
|
| [5] |
FU Y S, KANG N, YU Y P, et al. Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD[J]. Eur Respir Rev, 2022, 31(164):220028. DOI:10.1183/16000617.0028-2022 .
|
| [6] |
VOYNOW J A, SHINBASHI M. Neutrophil elastase and chronic lung disease[J]. Biomolecules, 2021, 11(8):1065. DOI:10.3390/biom11081065 .
|
| [7] |
VAN DIJK E M, CULHA S, MENZEN M H, et al. Elastase-induced parenchymal disruption and airway hyper responsiveness in mouse precision cut lung slices: toward an ex vivo COPD model[J]. Front Physiol, 2017, 7:657. DOI:10.3389/fphys.2016.00657 .
|
| [8] |
BOREL F, SUN H M, ZIEGER M, et al. Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema[J]. Proc Natl Acad Sci USA, 2018, 115(11):2788-2793. DOI:10.1073/pnas.1713689115 .
|
| [9] |
ROBERTONI F S Z, VELOSA A P P, OLIVEIRA L M, et al. Type V collagen-induced nasal tolerance prevents lung damage in an experimental model: new evidence of autoimmunity to collagen V in COPD[J]. Front Immunol, 2024, 15:1444622. DOI:10.3389/fimmu.2024.1444622 .
|
| [10] |
UPADHYAY P, WU C W, PHAM A, et al. Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD)[J]. J Toxicol Environ Health B Crit Rev, 2023, 26(5):275-305. DOI:10.1080/10937404.2023.2208886 .
|
| [11] |
PELLEGRINO R, VIEGI G, BRUSASCO V, et al. Interpretative strategies for lung function tests[J]. Eur Respir J, 2005, 26(5):948-968. DOI:10.1183/09031936.05.00035205 .
|
| [12] |
张迪, 管宇, 夏艺, 等. 慢性阻塞性肺疾病动物模型研究进展[J]. 第二军医大学学报, 2018, 39(3):302-307. DOI:10.16781/j.0258-879x.2018.03.0302 .
|
|
ZHANG D, GUAN Y, XIA Y, et al. Advances in animal models of chronic obstructive pulmonary disease[J]. Acad J Second Mil Med Univ, 2018, 39(3):302-307. DOI:10.16781/j.0258-879x.2018.03.0302 .
|
| [13] |
马宏境, 刘彬. 慢性阻塞性肺疾病发病机制的研究[J]. 医学信息, 2019, 32(10):50-52. DOI: 10.3969/j.issn.1006-1959.2019.10.018 .
|
|
MA H J, LIU B. Study on the pathogenesis of chronic obstructive pulmonary disease[J]. Med Inf, 2019, 32(10):50-52. DOI: 10.3969/j.issn.1006-1959.2019.10.018 .
|
| [14] |
罗玉馨, 胡晓佳, 曹竟尹, 等. 慢性阻塞性肺疾病动物模型的研究与开发[J]. 黑龙江科学, 2022, 13(18): 14-16. DOI:10.3969/j.issn.1674-8646.2022.18.004 .
|
|
LUO Y X, HU X J, CAO J Y, et al. Research and development of animal model of chronic obstructive pulmonary disease[J]. Heilongjiang Sci, 2022, 13(18): 14-16. DOI:10.3969/j.issn.1674-8646.2022.18.004 .
|
| [15] |
LÜTHJE L, RAUPACH T, MICHELS H, et al. Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model[J]. Respir Res, 2009, 10(1):7. DOI:10.1186/1465-9921-10-7 .
|
| [16] |
STEVENSON C S, BIRRELL M A. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance[J]. Pharmacol Ther, 2011, 130(2):93-105. DOI:10.1016/j.pharmthera.2010.10.008 .
|
| [17] |
WRIGHT J L, COSIO M, CHURG A. Animal models of chronic obstructive pulmonary disease[J]. Am J Physiol Lung Cell Mol Physiol, 2008, 295(1): L1-L15. DOI:10.1152/ajplung.90200.2008 .
|
| [18] |
TOLEDO A C, MAGALHAES R M, HIZUME D C, et al. Aerobic exercise attenuates pulmonary injury induced by exposure to cigarette smoke[J]. Eur Respir J, 2012, 39(2):254-264. DOI:10.1183/09031936.00003411 .
|
| [19] |
GASCHLER G J, BAUER C M T, ZAVITZ C C J, et al. Animal models of chronic obstructive pulmonary disease exacerbations[J]. Contrib Microbiol, 2007, 14:126-141. DOI:10.1159/000107059 .
|
| [20] |
GONG G, SHEN S P, SHEN S R, et al. YAP/TAZ-mediated nuclear membrane rupture in promoting senescence of skeletal muscle associated with COPD[J]. Respir Res, 2025, 26(1):98. DOI:10.1186/s12931-025-03170-4 .
|
| [21] |
KOGEL U, WONG E T, SZOSTAK J, et al. Impact of whole-body versus nose-only inhalation exposure systems on systemic, respiratory, and cardiovascular endpoints in a 2-month cigarette smoke exposure study in the ApoE mouse model[J]. J Appl Toxicol. 2021 Oct;41(10):1598-1619. DOI: 10.1002/jat.4149 .
|
| [22] |
梁小波, 吴德洪, 王星, 等. 鼻内滴注烟草提取物和脂多糖建立慢性阻塞性肺疾病小鼠模型的评价[J]. 吉林大学学报(医学版), 2019, 45(6):1454-1458, 1486. DOI:10.13481/j.1671-587x.20190645 .
|
|
LIANG X B, WU D H, WANG X, et al. Evaluation on mouse models of chronic obstructive pulmonary disease induced by intranasal instillation of cigarette smoke extract and lipopolysaccharide[J]. J Jilin Univ Med Ed, 2019, 45(6):1454-1458, 1486. DOI:10.13481/j.1671-587x.20190645 .
|
| [23] |
HIGASHI T, MAI Y, MAZAKI Y, et al. A standardized method for the preparation of a gas phase extract of cigarette smoke[J]. Biol Pharm Bull, 2016, 39(6):898-902. DOI:10.1248/bpb.b16-00062 .
|
| [24] |
LI W J, LI Y Y, WANG Q, et al. Therapeutic effect of phycocyanin on chronic obstructive pulmonary disease in mice[J]. J Adv Res, 2024, 66:285-301. DOI:10.1016/j.jare. 2024.01.009 .
|
| [25] |
PELGRIM C E, WANG L, PERALTA MARZAL L N, et al. Increased exploration and hyperlocomotion in a cigarette smoke and LPS-induced murine model of COPD: linking pulmonary and systemic inflammation with the brain[J]. Am J Physiol Lung Cell Mol Physiol, 2022, 323(3): L251-L265. DOI:10.1152/ajplung.00485.2021 .
|
| [26] |
陈亚红. 2022年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2022, 25(11): 1294-1304, 1308.
|
|
CHEN Y H. Interpretation of global strategy for the diagnosis, treatment, management and prevention of chronic obstructive pulmonary disease 2022 report[J]. Chin Gen Pract, 2022, 25(11):1294-1304, 1308. DOl:10.12114/j.issn.1007-9572.2022.01.302.
|